by MASA | Dec 19, 2024 | Drug Updates
The U.S. Food and Drug Administration (FDA) has approved VTAMA® (tapinarof) cream, 1%, for the treatment of mild, moderate, or severe atopic dermatitis (AD) in adults and children aged 2 years and older. This approval expands the use of VTAMA, previously approved for...
by MASA | Jul 31, 2024 | Drug Updates
The FDA approved Zoryve cream (0.15%) for mild to moderate atopic dermatitis this year for adults and children aged above 6 years old. Roflumilast cream (marketed under the name Zoryve) is a non-steroidal topical cream that is applied once daily to affected areas of...
by MASA | Jul 15, 2023 | Atopic Dermatitis / Eczema, Clinical Research
On July 11, 2023, MASA’s research team at Sneeze Wheeze and Itch Associates received great news regarding the positive top-line research results on the safety and efficacy of a non-steroidal topical treatment for Atopic Dermatitis (AD) in children. The SWIA...
by MASA | Jul 11, 2023 | Allergies, Uncategorized
Jennifer Gardner NP Jennifer has spent her career treating both pediatric and adult patients. Jennifer has spent the last 10 years in Palliative Care, treating medically complex patients, consulting on complex symptom management, across all disease processes. Learn...
by MASA | Jun 23, 2020 | Atopic Dermatitis / Eczema, News
It’s normal to have occasional itching due to dry skin, sunburn, or a bug bite. However, eczema is a much more serious condition that causes chronically itchy dry skin that can become raw, inflamed, and scaly. It’s estimated that 31.6 million people in the United...
